Clomid

Beligas Pharma Clomid 50Mg / 50 Tabs provides research-grade Clomiphene Citrate, a selective estrogen receptor modulator (SERM) used in studies investigating hormonal feedback, pituitary stimulation, and testosterone restoration after anabolic exposure.
Each tablet contains 50 mg of Clomiphene Citrate, manufactured under GMP-certified pharmaceutical standards, ensuring precision and consistency for hormonal and reproductive endocrinology research.

In scientific settings, Beligas Clomid 50 is employed to model post-cycle hormonal recovery, LH/FSH stimulation, and androgen receptor re-balancing.

How Clomiphene Citrate Works

Clomiphene Citrate operates by blocking estrogen receptors in the hypothalamus, which leads to increased secretion of LH and FSH, indirectly stimulating natural testosterone production.
In controlled laboratory conditions, Beligas Clomid 50 enables researchers to:

• Examine pituitary-gonadal signaling restoration,

• Analyze hormonal rebound efficiency and timing,

• Measure serum testosterone and estradiol ratios,

• Study post-anabolic endocrine normalization.

Its dual-isomer composition (enclomiphene + zuclomiphene) provides a balanced model for short- and mid-term hormonal recovery studies.

Research & Performance Insight

In endocrine and reproductive physiology research, Clomiphene Citrate (Clomid) is one of the most recognized SERMs for post-cycle hormonal reactivation.
Beligas Clomid 50 supports scientific investigations on:

• Restoring hypothalamic-pituitary-gonadal axis (HPGA),

• Balancing testosterone and estrogen levels,

• Receptor desensitization recovery,

• Hormonal adaptation after exogenous androgen exposure.

Its stable pharmacokinetic profile allows precise measurement of endocrine feedback and recovery speed.